Warsaw, Poland - Highp for Veeva Approved Email enables Veeva CRM customers to enhance email communication in a more interactive format and video content.
Highp offers a complete solution and guidelines to design and deliver new push-video services.
Marketers can now extend email campaigns to the new, more meaningful, and convincing services, with personal field force video invitations, interactivity, rich-video-content, and frictionless customer experience on any device. As a result, pharmaceutical companies improve access to HCPs, increase SOV and NPS.
- Finally, your representative can send Highp message using Veeva Approved Email.
Igor Gnot, CEO, Connectmedica
Igor Gnot, CEO, Connectmedica
For more information
Visit and follow us on the Highp showcase page at Linkedin for more up-to-date news. https://www.linkedin.com/showcase/highp
Watch Highp for Approved Email demo on Vimeo https://vimeo.com/462352593 or LinkedIn
Backgrounder:
Veeva is a leading CRM provider for pharmaceutical companies.
The list of Veeva customers includes Actelion, GSK, Astellas, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Teva, Coloplast, Daiichi-Sankyo, Lilly, Ipsen, Leo, Merck, Nestle, Novartis, Takeda, Vertex.
The list of Veeva customers includes Actelion, GSK, Astellas, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Teva, Coloplast, Daiichi-Sankyo, Lilly, Ipsen, Leo, Merck, Nestle, Novartis, Takeda, Vertex.
Highp is a new digital solution for accessing healthcare professionals developed by Connectmedica.
Available worldwide in over 40 markets. The list of Highp customers includes Roche, BMS, Abbott, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Teva, Daiichi-Sankyo, Ipsen, Leo, Novartis, and Vertex.
Available worldwide in over 40 markets. The list of Highp customers includes Roche, BMS, Abbott, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Teva, Daiichi-Sankyo, Ipsen, Leo, Novartis, and Vertex.